Native Ion Mobility-Mass Spectrometry-Enabled Fast Structural Interrogation of Labile Protein Surface Modifications at the Intact Protein Level.
Gongyu LiAshley PhetsanthadMin MaQinying YuAshita NairZhen ZhengFengfei MaKellen DeLaneySeungpyo HongLingjun LiPublished in: Analytical chemistry (2022)
Protein sialylation has been closely linked to many diseases including Alzheimer's disease (AD). It is also broadly implicated in therapeutics operating in a pattern-dependent (e.g., Neu5Ac vs Neu5Gc) manner. However, how the sialylation pattern affects the AD-associated, transferrin-assisted iron/Aβ cellular uptake process remains largely ill-defined. Herein, we report the use of native ion mobility-mass spectrometry (IM-MS)-based fast structural probing methodology, enabling well-controlled, synergistic, and in situ manipulation of mature glycoproteins and attached sialic acids. IM-MS-centered experiments enable the combinatorial interrogation of sialylation effects on Aβ cytotoxicity and the chemical, conformational, and topological stabilities of transferrin. Cell viability experiments suggest that Neu5Gc replacement enhances the transferrin-assisted, iron loading-associated Aβ cytotoxicity. Native gel electrophoresis and IM-MS reveal that sialylation stabilizes transferrin conformation but inhibits its dimerization. Collectively, IM-MS is adapted to capture key sialylation intermediates involved in fine-tuning AD-associated glycoprotein structural microheterogeneity. Our results provide the molecular basis for the importance of sustaining moderate TF sialylation levels, especially Neu5Ac, in promoting iron cellular transportation and rescuing iron-enhanced Aβ cytotoxicity.
Keyphrases
- mass spectrometry
- gas chromatography
- liquid chromatography
- multiple sclerosis
- ms ms
- capillary electrophoresis
- high performance liquid chromatography
- protein protein
- molecular dynamics simulations
- high resolution
- iron deficiency
- amino acid
- small molecule
- air pollution
- genome wide
- gene expression
- dna methylation
- cancer therapy
- high intensity
- cognitive decline
- single cell